VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 98 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,043,828 | +432.5% | 131,963 | +526.7% | 0.00% | – |
| Q1 2024 | $196,032 | +20.9% | 21,056 | +9.6% | 0.00% | – |
| Q4 2023 | $162,081 | -39.6% | 19,204 | -44.5% | 0.00% | – |
| Q3 2023 | $268,204 | -88.4% | 34,607 | -82.8% | 0.00% | -100.0% |
| Q2 2023 | $2,302,274 | +260.3% | 201,072 | +235.4% | 0.00% | – |
| Q3 2020 | $639,000 | -15.5% | 59,944 | +0.1% | 0.00% | – |
| Q2 2020 | $756,000 | -1.8% | 59,891 | -28.8% | 0.00% | – |
| Q1 2020 | $770,000 | -30.6% | 84,107 | +5.7% | 0.00% | – |
| Q4 2019 | $1,110,000 | -83.6% | 79,604 | -79.8% | 0.00% | -100.0% |
| Q3 2019 | $6,773,000 | -40.9% | 393,555 | -6.6% | 0.00% | -33.3% |
| Q2 2019 | $11,464,000 | +957.6% | 421,155 | +643.6% | 0.00% | – |
| Q1 2019 | $1,084,000 | +19.0% | 56,639 | -41.6% | 0.00% | – |
| Q4 2018 | $911,000 | +251.7% | 96,909 | +630.3% | 0.00% | – |
| Q2 2018 | $259,000 | -73.4% | 13,269 | -77.4% | 0.00% | – |
| Q4 2017 | $974,000 | – | 58,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $37,772,000 | 15.45% |
| EcoR1 Capital, LLC | 4,753,907 | $28,096,000 | 0.97% |
| ARMISTICE CAPITAL, LLC | 2,564,000 | $15,153,000 | 0.26% |
| Harvest Investment Services, LLC | 42,312 | $250,000 | 0.19% |
| Aevitas Wealth Management, Inc. | 22,000 | $130,000 | 0.09% |
| CAXTON ASSOCIATES LP | 136,592 | $807,000 | 0.08% |
| XTX Topco Ltd | 25,525 | $151,000 | 0.06% |
| BVF INC/IL | 140,000 | $827,000 | 0.04% |
| FIDUCIARY TRUST CO | 248,529 | $1,469,000 | 0.03% |
| MYDA Advisors LLC | 12,000 | $71,000 | 0.02% |